Cite
Banning AP, Serruys P, De Maria GL, et al. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study. Eur Heart J. 2021;doi: 10.1093/eurheartj/ehab703.
Banning, A. P., Serruys, P., De Maria, G. L., Ryan, N., Walsh, S., Gonzalo, N., Jan van Geuns, R., Onuma, Y., Sabate, M., Davies, J., Lesiak, M., Moreno, R., Cruz-Gonzalez, I., Hoole, S. P., Piek, J. J., Appleby, C., Fath-Ordoubadi, F., Zaman, A., Van Mieghem, N. M., Uren, N., Zueco, J., Buszman, P., Iniguez, A., Goicolea, J., Hildick-Smith, D., Ochala, A., Dudek, D., de Vries, T., Taggart, D., Farooq, V., Spitzer, E., Tijssen, J., & Escaned, J. (2021). Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study. European heart journal, . https://doi.org/10.1093/eurheartj/ehab703
Banning, Adrian P, et al. "Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study." European heart journal vol. (2021). doi: https://doi.org/10.1093/eurheartj/ehab703
Banning AP, Serruys P, De Maria GL, Ryan N, Walsh S, Gonzalo N, Jan van Geuns R, Onuma Y, Sabate M, Davies J, Lesiak M, Moreno R, Cruz-Gonzalez I, Hoole SP, Piek JJ, Appleby C, Fath-Ordoubadi F, Zaman A, Van Mieghem NM, Uren N, Zueco J, Buszman P, Iniguez A, Goicolea J, Hildick-Smith D, Ochala A, Dudek D, de Vries T, Taggart D, Farooq V, Spitzer E, Tijssen J, Escaned J. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study. Eur Heart J. 2021 Oct 07; doi: 10.1093/eurheartj/ehab703. Epub 2021 Oct 07. PMID: 34617993.
Copy
Download .nbib
